Targeting XIAP for the treatment of malignancy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The X-linked inhibitor of apoptosis protein (XIAP) is a critical caspase inhibitor, regulating programmed cell death.
• XIAP's role in blocking apoptosis makes it a promising therapeutic target for various malignancies.

Purpose of the Study:

• To review the development of novel therapeutic agents targeting XIAP.
• To discuss the progress of antisense oligonucleotides and small molecule inhibitors against XIAP.

Main Methods:

• Review of existing literature on XIAP inhibitors.
• Analysis of preclinical and clinical data for antisense oligonucleotides and small molecule inhibitors.

Main Results:

• Antisense oligonucleotides targeting XIAP have shown efficacy in vitro and are in clinical trials.
• Small molecule inhibitors targeting XIAP's baculovirus IAP repeat (BIR) 2 or BIR 3 domains are in preclinical development.

Conclusions:

• XIAP represents a significant target for anti-cancer drug development.
• Both antisense and small molecule approaches are advancing towards clinical application for treating cancer.